Incidence of hepatocellular carcinoma in patients with chronic liver disease due to hepatitis B or C and coinfected with the human immunodeficiency virus: A retrospective cohort study

Table 3 Incidence of hepatocellular carcinoma in patients with chronic liver disease due to hepatitis B or C, with and without human immunodeficiency virus

HIV	n	HCC	%	Patient-years	Rate × 100 patient-years	RR	95%CI	P value
+	399	10	2.5	3963.80	0.25	-	-	-
-	405	26	6.4	3624.50	0.72	2.98	1.43-6.18	0.003
Model 2: adjusted for age						1.29	0.58-2.87	0.529
Model 3: adjusted for age and DM						1.27	0.56-2.88	0.571
Model 4: adjusted for age, DM and alcohol						1.23	0.52-2.95	0.638

HIV: Human immunodeficiency virus; HCC: Hepatocellular carcinoma; RR: Rate ratio; DM: Diabetes mellitus.